Refractory Behçet disease succesfully treated with roflumilast-Reference-Cited by-同舟云学术

Refractory Behçet disease succesfully treated with roflumilast

Published:2023-05-25 Issue:9 Volume:48 Page:1060-1062
ISSN:0307-6938
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:

Author:

Peñuelas Leal Rodrigo¹^ORCID,Labrandero Hoyos Carolina¹^ORCID,Grau Echevarría Andrés¹^ORCID,Martínez-Doménech Alvaro¹^ORCID,Casanova Esquembre Andrés ¹,Zaragoza Ninet Violeta¹,Pérez Ferriols Amparo¹,Sánchez Carazo Jose Luis¹

Affiliation:

1. Consorci Hospital General Universitari de Valencia , Valencia , Spain

Abstract

We report the first case of refractory Behçet disease with spectacular response to roflumilast 250 μg per day and no notable adverse effects beyond a self-resolving headache.

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Link

https://academic.oup.com/ced/advance-article-pdf/doi/10.1093/ced/llad189/50825604/llad189.pdf

Reference5 articles.

1. Recent insights into the management of Behçet syndrome;Ozguler;J Inflamm Res,2021

2. Treating the different phenotypes of Behçet’s syndrome;Bettiol;Front Immunol,2019

3. Long-term clearance of severe plaque psoriasis with oral roflumilast;Gyldenløve;J Eur Acad Dermatol Venereol,2022

4. Criteria for diagnosis of Behçet’s disease;International Study Group for Behçet’s Disease;Lancet,1990

5. Rapid improvement of idiopathic aphthous ulcers with oral roflumilast therapy;Gyldenløve;Br J Dermatol,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roflumilast in Dermatology: A Newer Phosphodiesterase-4 Inhibitor;Indian Journal of Dermatology;2024-09-13

2. Severe multi‐refractory Sneddon–Wilkinson disease, with fast response to oral roflumilast treatment;Journal of the European Academy of Dermatology and Venereology;2023-12-07